Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar;17(1):42-51.
doi: 10.1007/s11901-018-0389-7. Epub 2018 Feb 22.

The assessment and management of pain in cirrhosis

Affiliations

The assessment and management of pain in cirrhosis

Matthew Klinge et al. Curr Hepatol Rep. 2018 Mar.

Abstract

Purpose of review: The treatment of pain in patients with cirrhosis is complicated by unpredictable hepatic drug metabolism and a higher risk of adverse drug reactions. We aimed to conduct a scoping review regarding pain management in cirrhosis.

Recent findings: Despite the high prevalence of pain in patients with cirrhosis, there is little literature to guide the management of pain in this population. Complex pain syndromes and disease-specific pain etiologies exist are common in patients with cirrhosis. There are numerous contraindications and limitations when considering pharmacotherapy for analgesia in cirrhosis, specifically with non-steroidal anti-inflammatory drugs (NSAIDS) and opioid medications. Non-pharmacologic therapies for pain have not been specifically assessed in this population.

Summary: As with other populations, a multi-dimensional treatment approach to pain with a focus on physical, behavioral, procedural and pharmacologic treatment is recommended when caring for patients with cirrhosis and pain. However, more research is needed to evaluate opioid-sparing and non-pharmacologic analgesia in this population.

Keywords: analgesia; chronic liver disease; cirrhosis; pain.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Shari Rogal reports grants from Gilead Sciences, outside of the submitted work. Matthew Klinge, Tami Coppler, Jane M. Liebschutz, Mohannad Dugum, Ajay Wassan, and Andrea DiMartini each declare no conflicts of interest. Human and Animal Rights and Informed Consent This article does not contain any studies with human or animal subjects performed by any of the authors

Figures

Figure 1
Figure 1
Pain Management in Cirrhosis: Multi-dimensional Treatment Approach

Similar articles

Cited by

References

    1. Rogal SS, Bielefeldt K, Wasan AD, Lotrich FE, Zickmund S, Szigethy E, DiMartini AF. Inflammation, psychiatric symptoms, and opioid use are associated with pain and disability in patients with cirrhosis. Clinical Gastroenterology and Hepatology. 2015 May 31;13(5):1009–16. Prospective study highlighting the prevalence of pain and opioid use among patients with cirrhosis. - PMC - PubMed
    1. Whitehead AJ, Dobscha SK, Morasco BJ, Ruimy S, Bussell C, Hauser P. Pain, substance use disorders and opioid analgesic prescription patterns in veterans with hepatitis C. Journal of pain and symptom management. 2008 Jul 31;36(1):39–45. - PubMed
    1. Silberbogen AK, Janke EA, Hebenstreit C. A closer look at pain and hepatitis C: preliminary data from a veteran population. Journal of rehabilitation research and development. 2007 Feb 15;44(2):231. - PubMed
    1. Rogal SS, Winger D, Bielefeldt K, Szigethy E. Pain and opioid use in chronic liver disease. Digestive diseases and sciences. 2013 Oct 1;58(10):2976–85. - PMC - PubMed
    1. Imani F, Motavaf M, Safari S, Alavian SM. The therapeutic use of analgesics in patients with liver cirrhosis: a literature review and evidence-based recommendations. Hepatitis monthly. 2014 Oct;14(10) Recent review of pain management in cirrhosis. - PMC - PubMed

LinkOut - more resources